BRIEF published on 06/11/2024 at 19:00, 5 months 11 days ago Molten Ventures Plc: HOL-Holding(s) in Company Voting Rights Shareholder Structure BlackRock Financial Instruments Molten Ventures
PRESS RELEASE published on 06/11/2024 at 18:55, 5 months 11 days ago Molten Ventures Plc: HOL-Holding(s) in Company Molten Ventures Plc discloses major holding by BlackRock, Inc. as of 07-Jun-2024. BlackRock holds 13.18% of voting rights in the company Voting Rights Molten Ventures Plc Notification Major Holding BlackRock Inc.
BRIEF published on 06/07/2024 at 19:00, 5 months 15 days ago Molten Ventures Plc: Major Holdings Notification by BlackRock, Inc. Voting Rights Molten Ventures Plc Major Holdings BlackRock, Inc. Financial Notification
PRESS RELEASE published on 06/07/2024 at 18:55, 5 months 15 days ago Molten Ventures Plc: HOL-Holding(s) in Company BlackRock, Inc. notifies Molten Ventures Plc of an acquisition of voting rights on 06-Jun-2024. Total voting rights held in issuer is 12.70% Acquisition Voting Rights Molten Ventures Plc Notification BlackRock Inc.
BRIEF published on 06/07/2024 at 08:05, 5 months 15 days ago Molten Ventures Announces Full Year Results Presentation Investor Presentation Webcast Full Year Results Venture Capital Molten Ventures
PRESS RELEASE published on 06/07/2024 at 08:00, 5 months 15 days ago Full year results presentation Molten Ventures Plc to hold full year results presentation via webcast for analysts and retail investors. Details available for live event on 12 June 2024 and Investor Meet Company session on 14 June Molten Ventures Plc Analysts Webcast Retail Investors Full Year Results Presentation
BRIEF published on 06/06/2024 at 19:00, 5 months 16 days ago Molten Ventures Plc: HOL-Holding(s) in Company Acquisition Voting Rights BlackRock Molten Ventures
PRESS RELEASE published on 06/06/2024 at 18:55, 5 months 16 days ago Molten Ventures Plc: HOL-Holding(s) in Company BlackRock, Inc. notifies an acquisition in Molten Ventures Plc, resulting in 12.05% of voting rights. Detailed TR-1 report available Voting Rights Molten Ventures Plc GROW BlackRock Inc. TR-1 Report
BRIEF published on 06/04/2024 at 19:00, 5 months 18 days ago Molten Ventures Plc: Major Shareholding Update by BlackRock, Inc. Voting Rights Shareholding BlackRock Financial Instruments Molten Ventures
PRESS RELEASE published on 06/04/2024 at 18:55, 5 months 18 days ago Molten Ventures Plc: HOL-Holding(s) in Company Notification of major holdings in Molten Ventures Plc by BlackRock, Inc. on 03-Jun-2024. Total voting rights of 12%, with 10.98% from direct shares and 1.02% from financial instruments Voting Rights Molten Ventures Plc Major Holdings Financial Instruments BlackRock Inc.
Published on 11/22/2024 at 23:55, 52 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 hour 17 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 hour 42 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 hours 17 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 6 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 6 hours 53 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 7 hours 51 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 8 hours 47 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 17 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 5 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
